<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>227</volume><submitter>Dehghani P</submitter><pubmed_abstract>The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. Patients with cardiovascular risk factors or established cardiovascular disease are more likely to experience severe or critical COVID-19 illness and myocardial injury is a key extra-pulmonary manifestation. These patients frequently present with ST-elevation on an electrocardiogram (ECG) due to multiple etiologies including obstructive, non-obstructive, and/or angiographically normal coronary arteries. The incidence of ST-elevation myocardial infarction (STEMI) mimics in COVID-19-positive hospitalized patients, and the association with morbidity and mortality is unknown. Understanding the natural history and appropriate ma</pubmed_abstract><journal>American heart journal</journal><pagination>11-18</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7229476</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>N&lt;/i>orth &lt;i>A&lt;/i>merican &lt;i>C&lt;/i>OVID-19 ST-Segment-Elevation &lt;i>M&lt;/i>yocardial &lt;i>I&lt;/i>nfarction (NACMI) registry: Rationale, design, and implications.</pubmed_title><pmcid>PMC7229476</pmcid><pubmed_authors>Wood DA</pubmed_authors><pubmed_authors>Grines CL</pubmed_authors><pubmed_authors>Dehghani P</pubmed_authors><pubmed_authors>Schmidt C</pubmed_authors><pubmed_authors>Henry TD</pubmed_authors><pubmed_authors>Giri J</pubmed_authors><pubmed_authors>Mahmud E</pubmed_authors><pubmed_authors>Garcia S</pubmed_authors><pubmed_authors>Bagai A</pubmed_authors><pubmed_authors>Garberich R</pubmed_authors><pubmed_authors>Saw J</pubmed_authors><pubmed_authors>Sharkey S</pubmed_authors><pubmed_authors>Kaul P</pubmed_authors><pubmed_authors>Davidson LJ</pubmed_authors><pubmed_authors>Welt FG</pubmed_authors><pubmed_authors>Shah B</pubmed_authors><pubmed_authors>Nayak K</pubmed_authors><pubmed_authors>Ly HQ</pubmed_authors><pubmed_authors>Meraj P</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>N&lt;/i>orth &lt;i>A&lt;/i>merican &lt;i>C&lt;/i>OVID-19 ST-Segment-Elevation &lt;i>M&lt;/i>yocardial &lt;i>I&lt;/i>nfarction (NACMI) registry: Rationale, design, and implications.</name><description>The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. Patients with cardiovascular risk factors or established cardiovascular disease are more likely to experience severe or critical COVID-19 illness and myocardial injury is a key extra-pulmonary manifestation. These patients frequently present with ST-elevation on an electrocardiogram (ECG) due to multiple etiologies including obstructive, non-obstructive, and/or angiographically normal coronary arteries. The incidence of ST-elevation myocardial infarction (STEMI) mimics in COVID-19-positive hospitalized patients, and the association with morbidity and mortality is unknown. Understanding the natural history and appropriate ma</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2026-06-03T01:52:03.918Z</modification><creation>2020-08-29T07:19:02Z</creation></dates><accession>S-EPMC7229476</accession><cross_references><pubmed>32425198</pubmed><doi>10.1016/j.ahj.2020.05.006</doi></cross_references></HashMap>